International Trade committee  Around 96% of the products we currently use to treat the three diseases of HIV, TB, and malaria are generics. That gives you an idea of the impact of generics in our medical operations: 96%. It's similar numbers—

International Trade committee  Yes.

International Trade committee  No, no, I'm not saying that. My apologies for the confusion. I'm saying that we, as well as the Global Fund and ministers of health around the world, are highly dependent on the continual availability of the generic competition that has brought the prices down, including for one

International Trade committee  It means that if the TPP gets in place in current form, we would be negatively impacted, because we would have to spend more on pharmaceuticals and have less capacity to have access to affordable generics. That will have an impact on human life and costs.

International Trade committee  The TPP is a missed opportunity to promote innovation on biomedical technologies. The first letter that we sent to the Canadian government and to all TPP countries nearly four years ago asked for a TPP that would promote innovation and access for all, and really brought the agend

International Trade committee  Specifically on the provision on data inclusivity, the initial demand was for 12 years, and the text is much better than the initial demand. I completely agree with the member of Congress who made that remark. Currently five to eight years is better than 12 years, but if you look

International Trade committee  Thank you for the opportunity to further elaborate. There's global recognition right now that the current research and development system that's on the capacity to charge high prices to recover research and development costs is failing in many different ways. I was at the World

International Trade committee  Thank you for the opportunity to further elaborate. MSF completely supports the capacity of pharmaceutical companies to make profits and to profit from bringing out new breakthroughs in pharmaceuticals. We have medical operations on hepatitis C, so we very much benefit from the

International Trade committee  Thank you for the opportunity. We strongly disagree with any assessment or statement made about the impact of stronger intellectual property protection on the prices of medicines. It's been amply demonstrated. We will provide written testimony where we highlight data that has b